Clínica De La Costa Ltda.   Report issue

Academic/Hospital Phase 3
Founded: Barranquilla Colombia

Organization Overview

First Clinical Trial
2020
NCT04183595
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinica de la Costa - Barranquilla, Colombia | Clínica De La Costa Ltda.

Active Ingredients

Drugs in Phase 3 Trials (1)

BDTH2 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mercury Poisoning (Phase 3)

Poisoning (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1